1. GSK allies with Innovax for COVID-19 vaccine R&D project— Zentalis Pharma raises $165M in IPO — Drug discovery in the age of coronavirus — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Mass exodus

Discussion in 'Insmed' started by anonymous, Jun 26, 2019 at 10:55 AM.

Tags: Edit
  1. anonymous

    anonymous Guest

    And toxic bosses...

  2. Trailblazer

    Trailblazer new user

    May 12, 2019
    Likes Received:
    “People don’t leave jobs, they leave toxic work cultures” toxic environments make people sick, make projects fail, and make the best employees quit .” By Dr Amina Aitsi-Selma.
    More than 10% of reps are gone, less than a year from launch.
  3. anonymous

    anonymous Guest

    The only reason it isn’t higher than 10% is that most companies haven’t sent offers yet. It will be 30-40% by Jan 2020
  4. anonymous

    anonymous Guest

    Good point. Management bragged about how much they paid out for the launch bonus and have been scrambling to recoup it ever since by setting unattainable goals. Less than half the teams made goal last quarter. Thanks for the 3k bonus Insmed. Cheap bastards